Among a group of high-risk patients who developed infective endocarditis (IE) after transcatheter aortic valve implantation, cardiac surgery failed to improve clinical outcomes when compared with ...

PARIS, France—A meta-analysis of landmark clinical trials comparing TAVI against surgical aortic valve replacement across the surgical-risk spectrum of patients with severe aortic stenosis showed ...

Background While female sex has historically been associated with worse outcomes following surgical aortic valve replacement, ...

LONDON — Continuing oral anticoagulant drugs rather than briefly stopping them during transcatheter aortic valve implantation (TAVI) failed to provide any benefits and, in fact, increased the risk for ...

What follows is an outsider's report on the next big phase of cardiology—the percutaneous treatment of valvular heart disease. I have little doubt that in 5 to 10 years, transcutaneous valves will be ...

Findings from the PARTNER 2 randomized trial indicate that transcatheter aortic valve implantation (TAVI) is noninferior to surgical aortic valve replacement (SAVR) in intermediate-risk patients with ...

TAVI has transformed treatment for patients who are too weak for open-heart surgery. It offers faster recovery, fewer complications, and a chance at a better quality of life. For decades, severe ...

Transcatheter aortic valve implantation (TAVI) is associated with faster and better recovery of left ventricular systolic function than surgical aortic valve replacement (SAVR) in high-risk ...